Showing 21-30 of 38 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Beta cell prohormones as biomarkers of SC-beta cell graft function in T1D | The University of British Columbia | C. Bruce Verchere | Cures | 01-January-2026 to 31-December-2026 | $299,999.83 |
| Developing a Curriculum and eLearning Course for Clinicians Delivering Cell Therapies for People with Type 1 Diabetes | The University of Alberta | Peter Senior | Cures | 01-January-2026 to 31-December-2027 | $399,594.73 |
| AI-driven benchmarking for understanding and improving SC-islets | The University of Alberta | Patrick MacDonald | Cures | 01-May-2025 to 30-April-2028 | $750,000.00 |
| Graft localized therapeutic delivery systems to enhance beta cell engraftment | The University of Alberta | Gregory Korbutt | Cures | 01-October-2023 to 30-September-2026 | $974,655.00 |
| Combinatory Technologies to Optimized Localized Drug Delivery for Cell Therapies in T1D | The University of Alberta | Gregory Korbutt | Cures | 01-July-2024 to 30-June-2027 | $896,925.01 |
| Tirzepatide with fully automated insulin delivery | The Research Institute of the McGill University Health Centre | Ahmad Haidar | Improving Lives | 01-September-2025 to 31-August-2028 | $1,885,343.91 |
| Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D | The Governing Council of the University of Toronto | Xiao Yu (Shirley) Wu | Cures | 01-April-2023 to 31-March-2027 | $899,710.00 |
| Synthetic vascularizing biomaterial platform for subcutaneous islet transplantation and immunomodulation | The Governing Council of the University of Toronto | Sean Kinney | Cures | 01-March-2025 to 29-February-2028 | $237,690.00 |
| Vascular regenerative biomaterial (MAA) for islet transplantation | The Governing Council of the University of Toronto | Michael Sefton | Cures | 01-August-2021 to 30-November-2025 | $506,807.41 |
| Picosecond Infrared Laser (PIRL)-based spatial imaging mass spectrometry (proteomics) and transcriptomics of beta-cells in live human pancreas slices afflicted by T1D T-cell immune injury | The Governing Council of the University of Toronto | Herbert Gaisano | Cures | 01-April-2026 to 31-March-2027 | $199,430.00 |